Mescaline

BRIGHT GREEN CORPORATION GAINS MOMENTUM FOR THEIR “DRUGS MADE IN AMERICA” PLATFORM WITH APPROVAL FOR THE RESEARCH, PRODUCTION AND MANUFACTURING OF ALL SCHEDULE I AND SCHEDULE II PLANT-BASED DRUGS

Retrieved on: 
Thursday, February 22, 2024

GRANTS, N.M., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”) company announced today that final approval has been received from the New Mexico Board of Pharmacy and the DEA for unique licensing that allows Bright Green to register, license, and authorize Schedule I and Schedule II plant-based drugs and Active Pharmaceutical Ingredients (APIs) for research, production, and manufacturing purposes. Schedule I Substances include Psilocybin, psilocybin, mescaline, peyote, ibogaine Schedule II Substances: Opium, poppy straw, raw opium, opium extracts, powdered opium, granulated opium, tincture of opium, opium fluid extracts, opium straw concentrates, pending: erythroxylon coca (cocaine)

Key Points: 
  • Achieving this substantial approval allows Bright Green to bring their deep expertise to these issues to help propel our Drugs Made in America movement forward.
  • The research will be conducted the Company’s C2 team in Albuquerque, New Mexico, and the reshoring of production and manufacturing to the U.S. will take place at the company’s Grants, New Mexico facility.
  • Medical plants will be produced in climate-controlled glass greenhouses engineered to ensure quality and predictability, laying a roadmap for guaranteed supply contracts with both federal government entities and other pharmaceutical interests.
  • Bright Green expects to be the first company in almost 100 years to produce, manufacture and supply API for Schedule I and Schedule II controlled substances and to deliver on contracts of this type.

Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property

Retrieved on: 
Friday, February 23, 2024

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today announced the company has agreed to sell one of its cancer-related patent portfolios for an undisclosed amount.

Key Points: 
  • Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today announced the company has agreed to sell one of its cancer-related patent portfolios for an undisclosed amount.
  • The patents and applications being sold disclose and claim the synergistic combination of cannabidiol and second therapeutic agents for the treatment of cancer.
  • The divested portfolio includes patents issued in the U.S., Australia, Canada, China, Europe, and Japan, with patent applications pending in Canada, Israel, and Korea.
  • Enveric retains no ownership rights in the divested portfolio, any companies owned by, or to be formed by the recipients.

Using ‘trip killers’ to cut short bad drug trips is potentially dangerous

Retrieved on: 
Wednesday, February 14, 2024

As interest in psychedelics has grown, so has interest in ways to end a bad trip.

Key Points: 
  • As interest in psychedelics has grown, so has interest in ways to end a bad trip.
  • Recent research reveals that people are giving potentially dangerous advice on social media on how to stop a trip that is less than pleasurable.
  • One of the earliest descriptions of a psychedelic experience in western literature can be found in Aldous Huxley’s 1953 book The Doors of Perception.
  • Research shows that if someone is in a bad mood or depressed then they are more likely to have a bad trip, as are people who take too high a dose.

Trip killers

  • Few clinical studies have examined trip killers, but one has found that ketanserin – a drug used to treat high blood pressure – reverses the psychedelic effects of LSD.
  • A recent article in the Emergency Medical Journal analysed posts on Reddit about trip killers.
  • Trip killers were discussed most often for LSD (235 posts), magic mushrooms (143 posts) and MDMA (21 posts).

Receptor blocking

  • To kill a trip then, one simply has to give the drug user another drug that blocks (rather than activates) the 5-HT2A receptor.
  • Many prescription drugs can do this and they tend to be antipsychotic drugs.
  • Quetiapine from the list above is one popular example, while another antipsychotic, olanzapine, was mentioned in 14 posts in that study.
  • Similarly, the atypical antidepressants trazodone and mirtazapine also block the 5-HT2A receptor.


Colin Davidson has previously received funding from the National Institute on Drug Abuse (NIH, USA) and the European Community for projects related to stimulant drug abuse and novel psychoactive compounds respectively. He is currently a paid consultant with the Defence Science Technology Laboratory (MOD) working on new psychoactive compounds.

Police Seizures of Psychedelic Drugs Are Soaring Throughout the United States

Retrieved on: 
Tuesday, February 6, 2024

Their analysis of national and state-level trafficking data revealed that across the country, seizures of psilocybin rose from 402 confiscations in 2017 to 1,393 confiscations in 2022.

Key Points: 
  • Their analysis of national and state-level trafficking data revealed that across the country, seizures of psilocybin rose from 402 confiscations in 2017 to 1,393 confiscations in 2022.
  • The amount of the seized drugs nearly quadrupled, from 226 kilograms to 844 kilograms in the same time frame.
  • "Our findings, which uncover an increase in confiscations of psilocybin, suggest that popularity and availability of this psychedelic may be increasing," said study lead author Joseph Palamar, PhD, MPH.
  • For example, some of the reports in the data reference large shipments that may have been headed to other states for sale.

Oakland activists file statewide ballot initiative seeking safe and legal access to psychedelics for medical and therapeutic uses

Retrieved on: 
Saturday, October 28, 2023

Dave Hodges, proponent of safe access to psychedelics for medical, therapeutic and spiritual use, today submitted the Psychedelic Wellness & Healing Initiative to the California Attorney General’s office for the 2024 ballot.

Key Points: 
  • Dave Hodges, proponent of safe access to psychedelics for medical, therapeutic and spiritual use, today submitted the Psychedelic Wellness & Healing Initiative to the California Attorney General’s office for the 2024 ballot.
  • If it wins passage, the initiative will allow for the sale, possession and use of psychedelics including Psilocybin, MDMA, DMT, and Mescaline for medical and therapeutic purposes.
  • Hodges, founder of the Oakland-based Church of Ambrosia , said the initiative will need 546,651 valid signatures to qualify for the 2024 ballot.
  • The initiative also would create a statewide framework for regulating possession, use, cultivation and production of substances for medical and therapeutic use.

Church of Ambrosia Responds to Gov. Newsom’s Veto of SB58

Retrieved on: 
Thursday, October 12, 2023

The Church of Ambrosia, the world’s largest psychedelic church, today offered a mixed response to California Gov.

Key Points: 
  • The Church of Ambrosia, the world’s largest psychedelic church, today offered a mixed response to California Gov.
  • Gavin Newsom’s veto of SB58, the bill that sought to decriminalize the use of certain psychedelic drugs, such as psilocybin, DMT, and mescaline.
  • Dave Hodges, founder of the Church, said the Senate measure would have been “a great step forward” as it would have enabled decriminalization to move ahead.
  • The Church, in partnership with the Oakland-based Hyphae Labs, has been an early and vigorous leader on safety issues.

CSE Bulletin: New Listing - Lophos Holdings Inc. (MESC)

Retrieved on: 
Thursday, August 31, 2023

Toronto, Ontario--(Newsfile Corp. - Le 31 août/August 2023) - The common shares of Lophos Holdings Inc. have been approved for listing on the CSE.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - Le 31 août/August 2023) - The common shares of Lophos Holdings Inc. have been approved for listing on the CSE.
  • Lophos Holdings Inc. pertains to the cultivation and research of Lophophora williamsii (“peyote cactus”).
  • Les actions ordinaires de Lophos Holdings Inc. ont été approuvées pour leur inscription au CSE.
  • Lophos Holdings Inc. se rapporte à la culture et à la recherche de Lophophora williamsii (« cactus peyotl »).

How drugs can warp your sense of time

Retrieved on: 
Thursday, August 10, 2023

Where trips to the dentist flew by in a second and holidays felt like they lasted forever.

Key Points: 
  • Where trips to the dentist flew by in a second and holidays felt like they lasted forever.
  • Time altering pills may sound like science fiction but the time warping effects of psychoactive drugs suggest that deliberate time manipulation may be possible.
  • Other drugs can scramble our sense of time completely.
  • Pregabalin, a drug used to treat epilepsy and anxiety, and anti-anxiety drug Xanax, both slow
    the passage of time.

So why do drugs warp time?

    • Drugs associated with increases in the passage of time are stimulants, which cause increased activity and excitation across the areas of the brain associated with cognitive function.
    • Drugs also affect behaviour and emotions, both of which can twist our experience of time.
    • Drugs such as cocaine and MDMA can have powerful effects on mood, inducing feelings of happiness and euphoria.
    • What you do while taking drugs will contribute to the sensation that time is bending.

The aftermath

    • The neurochemical, emotional and cognitive effects of comedowns create the perfect environment for time to drag.
    • The combination of exhaustion and low mood means that much of the recovery period is spent wondering “when will this end”, which also exaggerates the slowing of time.

Intertwined with human history and nature

    • They involve drinking a liquid brewed from leaves from the Psychotria viridis shrub and stalks of the Banisteriopsis caapi vine.
    • The brew causes changes in the state of consciousness, resulting in hallucinations and a significant change in the flow of time.
    • Nowadays, ayahuasca ceremonies attract tourists from across the world seeking to experience altered states of consciousness and spirituality.
    • Ruth Ogden receives funding from receives funding from The British Academy, The Wellcome Trust, The Economic and Social Research Council and CHANSE.

Neural Therapeutics Receives Key Permission from Peruvian Government to Harvest and Work with the San Pedro Cactus Containing Mescaline

Retrieved on: 
Thursday, July 27, 2023

Toronto, Ontario--(Newsfile Corp. - July 27, 2023) - Neural Therapeutics Inc. ("Neural" or the "Company") is pleased to announce that after nearly 11 months of a rigorous review process, the Company has received a key permission from Servicio Nacional Forestal y de Fauna Silvestre ("SERFOR"), the National Service for Forest and Wildlife, part of Peru's Ministry of Agriculture, which is in charge of regulating forest and wildlife. Due to the special nature of the Company's request, the application was further reviewed and approved by The Ministry of the Environment (MINAM). This permit provides the Company with access to genetic resources and their derivatives for the evaluation of the mescaline-containing cactus species of the Echinopsis genus (commonly known as San Pedro or Huachuma) for possible medicinal purposes.

Key Points: 
  • Mescaline is a chemical compound (and classified as a psychedelic with potential medicinal/therapeutic applications) derived from the Peyote and San Pedro cacti.
  • In comparison, the San Pedro cactus grows significantly faster with a greater biomass and is harvestable in a shorter time frame.
  • In 2022, the Peruvian Ministry of Culture declared the traditional use of San Pedro cactus in northern Peru as cultural heritage.
  • Additionally, we will donate specimens to a Peruvian sanctioned local herbarium for future scientific studies and species preservation."

Lucy Scientific Discovery Files Amendment with Health Canada to Expand its List of Controlled Substances to Include Cocaine and Heroin; This Expansion Represents an Effort to Supply Harm Reduction Programs Around the World

Retrieved on: 
Thursday, February 16, 2023

The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.

Key Points: 
  • The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.
  • Currently, Lucy focuses on the development of psychedelic drugs for research purposes and hopes to supply safe access programs in the future.
  • The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B.
  • “We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.